title: The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
authors.forename: Xiang Yang
authors.initials: XY
authors.lastname: Zhang
authors.forename: Dong Feng
authors.initials: DF
authors.lastname: Zhou
authors.forename: Lian Yuan
authors.initials: LY
authors.lastname: Cao
authors.forename: Gui Ying
authors.initials: GY
authors.lastname: Wu
authors.forename: Yu Cun
authors.initials: YC
authors.lastname: Shen
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D011388:Prolactin / Q000097:blood*; D011569:Psychiatric Status Rating Scales; D018967:Risperidone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D013482:Superoxide Dismutase / Q000097:blood*
chemical_list: D014150:Antipsychotic Agents; D011388:Prolactin; D013482:Superoxide Dismutase; D006220:Haloperidol; D018967:Risperidone